India's Bharat Biotech seeks emergency use approval for vaccine in Philippines


  • World
  • Thursday, 21 Jan 2021

FILE PHOTO: Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi

MANILA (Reuters) - India's Bharat Biotech submitted on Thursday an application for the emergency use of its COVID-19 vaccines in the Philippines, Food and Drug Administration chief Rolando Enrique Domingo said.

Bharat Biotech, which has developed COVAXIN with the Indian Council of Medical Research, is the fourth vaccine maker to apply for emergency use in the Philippines.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Death toll from strikes on eastern Congo camps rises to 18
African experts highlight soil degradation, climate impacts on crop yields
Brazil floods death toll rises to 90, dozens still stranded
Ethiopia earns 835 mln USD from coffee export in 9 months
Floods death toll in Kenya rises to 238 as heavy rains continue
African Union launches strategy to combat desertification
Zimbabwean finance minister urges market adoption of new currency ZiG
Trump seeks records about evidence handling in latest bid to delay documents case
German exports shrink by 1.1 pct in Q1
Bangladesh's forex reserves reach nearly 20 bln USD in April

Others Also Read